Company Filing History:
Years Active: 2024-2025
Title: Biography of Colin Exline
Introduction: Colin Exline is an innovative inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of adenoviral expression vectors and synthetic receptors. With a total of two patents to his name, Exline continues to push the boundaries of scientific research and application.
Latest Patents: Colin Exline's latest patents include "Adenoviral expression vector and methods and cell lines for production" and "Modular synthetic receptors and methods of use." The first patent provides an adenovirus expression vector that is replication incompetent and includes methods for synthesizing the vector. The second patent focuses on synthetic receptors that can bind to ligands and undergo proteolytic cleavage to release functional domains, enhancing their utility in various applications.
Career Highlights: Colin Exline is currently employed at Lung Biotechnology Pbc, where he applies his expertise in biotechnology to develop innovative solutions. His work has been instrumental in advancing the understanding and application of adenoviral vectors and synthetic biology.
Collaborations: Throughout his career, Colin has collaborated with notable colleagues, including Sean Stevens and Jintang Du. These collaborations have fostered a dynamic environment for innovation and research.
Conclusion: Colin Exline is a prominent figure in the field of biotechnology, with a focus on adenoviral vectors and synthetic receptors. His contributions through patents and
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.